Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 12 | $1,207,420 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
20 Aug 2024 18:46 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 19 Aug 2024 | Sale | 9,733 | 15.28 | 148,720 | D |
11 Jun 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 10 Jun 2024 | Sale | 975 | 14.79 | 14,420 | D |
03 May 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 02 May 2024 | Sale | 3,503 | 16.94 | 59,341 | D |
09 Apr 2024 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 08 Apr 2024 | Sale | 2,716 | 17.87 | 48,535 | D |
27 Mar 2024 19:57 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 27 Mar 2024 | Sale | 5,434 | 17.9 | 97,269 | D |
27 Feb 2024 18:13 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, CHIEF FINANCIAL OFFICER | 26 Feb 2024 | Sale | 772 | 24.67 | 19,045 | D |
21 Nov 2023 18:00 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 20 Nov 2023 | Sale | 5,108 | 22.64 | 115,645 | D |
23 Aug 2023 19:31 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 21 Aug 2023 | Sale | 10,000 | 28.997 | 289,970 | D |
12 Jun 2023 20:48 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 08 Jun 2023 | Sale | 974 | 25.02 | 24,369 | D |
19 May 2023 18:48 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 17 May 2023 | Sale | 15,310 | 22.5 | 344,475 | D |
07 Apr 2023 20:37 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 06 Apr 2023 | Sale | 1,916 | 18.16 | 34,795 | D |
27 Feb 2023 21:00 | ACAD | ACADIA PHARMACEUTICALS INC | SCHNEYER MARK C. | EVP, Chief Financial Officer | 24 Feb 2023 | Sale | 577 | 18.78 | 10,836 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)